The University of Informatics Sciences recieved CITMA Provincial Award for Technological Innovation.
Because of the importance of the solution, its social impact and economic contribution, four computer systems developed at the University of Informatics Sciences (known as UCI) for Cuban public health, Computerization of Entities and Electronic Government; Respectively, received the CITMA Provincial Award for Technological Innovation on Friday for the Cuban Science Day held at the Institute of Tropical Medicine Pedro Kourí (IPK).
The XAVIA HIS, XAVIA RIS, XAVIA PACS), the Clinical Trials Management System (XAVIA Clinics), as well as the Health System of the Ministry of Science, Technology, and Environment (CITMA) Management of the Tribunals and the System of the planning of activities, SIPAC.
For its contributions to economic and social development in the province, the CITMA delegation in Havana also recognized the University of Informatics Sciences as an institution.
According to the head of the Clinical Trials Project of the Medical Informatics Center (CESIM) of the UCI, Ing. Yasmani Ledesma Valdés, the Clinical Trials Management System, XAVIA Clinicas, was designed with the aim of computerizing the design and Conduction of clinical trials or Data Collection Notebook (CRD).
This system has four modules: Company Management, study Management , Send Data, and Extract Data.
It is currently used in the country's 15 provinces in 176 clinical sites (141 polyclinics, primary health care and 35 hospitals and specialized centers, secondary health care).
More than 500 users from all over the country have been trained to work on the system. In addition, 13 clinical trials are conducted, ranging from Phase I to Phase IV trials with a total of 1991 patients included.
In addition, the entire process of designing and conducting clinical trials in four trials in the system has been completed. These include the CIMAvax-EGF vaccine assay in lung Phase IV predictor; Vaxira for the treatment of ovarian epithelial cancer; Vaxira in a pediatric patient diagnosed with neuroblastoma, Ewing sarcoma or nephroblastoma, and NacGM3 / VSSP as subcutaneous immunopotentiator in the treatment of AIDS patients refractory to antiretroviral therapy. Phase I / II.
It was released by the National Center for Software Quality (Calisoft) and evaluated by the Center for State Control of Medicines, Equipment and Medical Devices (CECMED) to expand its use as CRDe to all entities conducting clinical trials in the country, With national and foreign institutions.
It has reported savings to the country of more than USD 1 million for the acquisition of software of this type, maintenance services, support and training of personnel. And it has reported to the Center for Molecular Immunology savings of more than 50,000 CUCs in 17 clinical trials for CRD sheet printing concepts.
The production of software in our center, corroborated the main analyst of the Integrated Health System, Mr. Pedro Ernesto Salas Oliva, in addition to taking advantage of trade opportunities, especially at an international level, to contribute economically to the country, focuses on computerizing the different Institutions in Cuba.
"These actions, not only contribute to the computerization of society, to improve the country's economy and technological sovereignty, but also contributes to the health personnel entering the digital age to perform their daily activities, which can report speed and a higher quality of services, "said Salas Oliva.